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Abstract  
Background: The potential for machine learning to disrupt the medical profession is the subject 
of ongoing debate within biomedical informatics.  
Objective: This study aimed to explore psychiatrists’ opinions about the potential impact 
innovations in artificial intelligence and machine learning on psychiatric practice  
Methods: In Spring 2019, we conducted a web-based survey of 791 psychiatrists from 22 
countries worldwide. The survey measured opinions about the likelihood future technology 
would fully replace physicians in performing ten key psychiatric tasks. This study involved 
qualitative descriptive analysis of written responses (“comments”) to three open-ended questions 
in the survey.  
Results: Comments were classified into four major categories in relation to the impact of future 
technology on: (1) patient-psychiatrist interactions; (2) the quality of patient medical care; (3) the 
profession of psychiatry; and (4) health systems. Overwhelmingly, psychiatrists were skeptical 
that technology could replace human empathy. Many predicted that ‘man and machine’ would 
increasingly collaborate in undertaking clinical decisions, with mixed opinions about the benefits 
and harms of such an arrangement. Participants were optimistic that technology might improve 
efficiencies and access to care, and reduce costs. Ethical and regulatory considerations received 
limited attention.  
Conclusions: This study presents timely information on psychiatrists’ views about the scope of 
artificial intelligence and machine learning on psychiatric practice. Psychiatrists expressed 
divergent views about the value and impact of future technology with worrying omissions about 
practice guidelines, and ethical and regulatory issues. 
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Introduction 
Background 
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Worldwide it is estimated that 1 in 6 people suffer from mental health disorders, and the personal 
and economic fallout is immense.[] Psychiatric illnesses are among the leading causes of 
morbidity and mortality; by 2030 this burden is estimated to cost the global economy $16 
trillion. [] Among younger people, suicide is the second or third leading cause of death.[] Older 
generations are also affected by mental illness: currently, an estimated 50 million people suffer 
from dementia worldwide, and the World Health Organization (WHO) predicts this will rise to 
80 million by 2030.[] Stigmatization, low funding and lack of resources – including considerable 
shortages of mental health professionals – pose significant barriers to psychiatric care.[] 
According to recent WHO data, discrepancies in per-capita availability of psychiatrists is 100 
times lower than in affluent countries.[] Indeed, even in wealthy countries, such as the USA – 
which has around 28,000 psychiatrists[] – those living in rural or poverty-stricken urban 
communities experience inferior access to adequate mental health care. It is anticipated that 
demographic and societal changes will put even greater pressure on mental health resources in 
the forthcoming decades.[] These pressures include: ageing populations; increased urbanization 
(with associated problems of overcrowding, polluted living conditions, higher levels of violence, 
illicit drugs, and lower levels of social support); migration, at the highest rate recorded in human 
history; and the use of electronic communications which has amplified concerns about the effects 
of the internet on mental health and sociality.[]  
Against these myriad challenges, recent debate has centered on the potential of big data, machine 
learning (ML) and artificial intelligence (AI) to revolutionize the delivery of healthcare.[] Some 
medical informaticians argue that the core functions of physicians – gathering and monitoring 
patient information, diagnostics, prognostics, and formulating personal treatment plans are 
vulnerable to disintermediation.[] Other AI experts predict that, in the future, physicians will 
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always play a role in medical care with ‘man and machine’ working as ‘team-players’.[] Aside 
from forecasts by medical professionals and informaticians, there is increasing interest among 
patients to use mobile technologies to monitor their health. For example, a recent US survey 
reported that 70 per cent of patients had an interest in using mobile technologies to monitor their 
mental health.[]  
Objectives 
Amid the debate, hype, and uncertainties about the impact of AI on the future of medicine, 
limited attention has been paid to the views of practicing clinicians including psychiatrists[] – 
though in the last year there is evidence that this changing.[] To address this research gap, we 
employed quantitative methods to investigate the global psychiatric community’s opinions about 
the potential impact of future technologies to replace key physician tasks in mental health care. 
Given the potential for more nuanced insights acquired through qualitative methods, we 
incorporated 3 open-ended questions into the survey (see Table 1). Our aim was to provide a 
preliminary investigation into psychiatrists’ views on the themes of the quantitative online 
survey: namely, participants’ perspectives on the influence (if any) of AI/ML on the profession, 
including potential benefits and harms to psychiatric practice. To our knowledge, this is the first 
qualitative investigation of psychiatrists’ opinions about AI/ML on the future of the profession.  
 
 
 
Methods 
Main Survey  
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A complete description of the survey methods and quantitative results has been published 
previously.[] In summary, we conducted an anonymous global Web-based survey of 
psychiatrists registered with Sermo, a secure digital online social networking for physicians, and 
for conducting survey research.[] Participants were randomly sampled from membership of the 
Sermo.org []. This is the one of the largest online medical networks in the world, with 800,000 
users from 150 countries across Europe, North and South America, Africa, and Asia, employed 
in 96 medical specialties. Users are registered and licensed physicians. Invitations were emailed 
and displayed on the Sermo.org home pages of randomly selected psychiatrists in May 2019, 
with quasi-stratification: the aim was to recruit one third of participants from the USA, one third 
from Europe, and one third from the rest of the world. As this was an exploratory study, we 
aimed to target a sample size of roughly 750 participants to approximate a previous survey of 
general practitioners’ views, on which the current project was based.[] The survey was closed 
with 791 respondents. This was an anonymous survey and an analysis of de-identified survey 
data was deemed exempt research by Duke University Institutional Review Board. Invited 
participants were advised that their identity would not be disclosed to the research team, and all 
respondents gave informed consent before participating.  
The study team devised an original survey instrument specifically designed to investigate 
psychiatrists’ opinions about the impact of future technologies on primary care (see Multimedia 
Appendix 1). We avoided terms such as “algorithms” in favor of generic descriptors such as 
“machines” and “future technology.” This was in part to avoid any confusion among physicians 
unfamiliar with this terminology and to avert technical debates about the explanatory adequacy 
of specific AI terms of art. The survey was developed in consultation with psychiatrists in the 
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USA (n=2) and was pretested with psychiatrists from other countries (n=9) to ensure face 
validity. 
Qualitative Component  
To maximize response rate for the qualitative component, the survey instrument included three 
open-ended questions that allowed participants to respond in more detail on the topic of the 
questionnaire (see Table 1). Comments not in English were translated by Sermo; this process 
was undertaken by experienced medical text translators, subject to further proofreading and in-
house checks. Descriptive content analysis was used to investigate these responses.[] Responses 
were collated and imported into QCAmap (coUnity Software Development GmbH) for analysis. 
The comment transcripts were initially read numerous times by CB, CL, and MLC to achieve 
familiarization with the participant responses. Afterward, an inductive coding process was 
employed. This widely used method is considered an efficient methodology for qualitative 
data.[] A multistage analytic process was conducted: First, we defined the three open-ended 
questions as our main research questions. Second, we worked through the responses line by line. 
Brief descriptive labels (“codes”) were applied to each comment. Multiple codes were applied to 
comments with multiple meanings. Comments and codes were reviewed by CB, CL and MLC. 
Third, after working through a significant amount of text, CB, CL and MLC met to discuss 
coding decisions, and subsequent revisions were made. This process led to a refinement of codes. 
Finally, first-order codes were grouped into second-order categories based on the commonality 
of their meaning to provide a descriptive summary of the responses.[] We followed the rules of 
summarizing qualitative content analysis for this step.[]  
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Results 
Overview 
As outlined in the quantitative survey, 791 psychiatrists responded from 22 countries 
representing North America, South America, Europe, and Asia-Pacific.[] Of the participants, 
70% were male; and 61% were aged 45 or older (see Table 2). All respondents left comments 
(26,470 words) which were typically brief (1 phrase or 2 sentences).  
As a result of the iterative process of content analysis, four major categories were identified in 
relation to the impact of future technology on: (1) patient-psychiatrist interactions; (2) the quality 
of patient medical care; (3) the profession of psychiatry; and (4) health systems. These categories 
were further subdivided into themes, which are described below with illustrative comments; 
numbers in parentheses are identifiers ascribing comments to individual participants. 
 
Impact of Future Technology on Patient-Psychiatrist Interactions 
A foremost concern of future technology on psychiatry was the perceived “loss of empathy”, and 
absence of a therapeutic interpersonal relationship in the treatment of mental health patients.  
Empathy  
Numerous comments reflected considerable skepticism that future technology could provide 
empathic care; an underlying assumption was this was necessarily a human capacity. Some 
participants were adamant about this; for example: 
It is a total illusion. A robot is incapable of being empathetic in a caring 
relationship. [Participant 259] 
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Psychiatry is incompetent and incomplete without empathy. I doubt a machine 
could ever empathize with a live human being... I don’t think affect of patient and 
mood, feelings, emotions can be analyzed accurately. [Participant 61] 
Lack of empathy will be huge. [Participant 397] 
Although most responses were short – for example, “no empathy”, or “lack of empathy and 
humanity” – a significant number of respondents also perceived limitations that technology could 
ever accurately detect human emotions via verbal or nonverbal cues; for example,  
AI cannot properly assess the human side of the problems including thing as basic 
as facial expression and posture, eye contact, etc. [Participant 80] 
AI could be overwhelmed as it tries to sort out body language, affect, lying, and 
conversational subtleties. [Participant 462] 
It won’t be able to read the subtext of conversation. [Participant 404] 
Only a small minority of comments hinted at the benefits of machine technology in 
augmenting empathetic care including the detection of emotions: 
Objectively (without countertransference) giving weight to micro-facial 
recognition/paired with some sort of emotional detection recognition software. 
[Participant 53] 
May ask questions in a non-judgmental way – likely to emulate empathy. 
[Participant 548] 
The therapeutic relationship 
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Another dominant view was the broader implications of technology for the therapeutic 
relationship with the majority of comments anticipating communication problems, lack of 
rapport, and the potential harms to patients. Notably, the majority of responses assumed that 
future technology would incur loss of contact with clinicians and even incur harm. For example: 
Complete lack of human interactions central to psychiatry services! [Participant 
35] 
Absence of human relationships that are so vital for healing. [Participant 438] 
Dehumanizing: patients could feel invalidated and ignored, loss of therapeutic 
relationship. [Participant 35] 
It will increase psychiatric illness. Clients will be more isolated and seek personal 
interaction. [Participant 433] 
Some respondents indicated that patients would prefer to seek help from humans; for example:  
Patients are still going to want to talk to an actual human being about deep 
seated thoughts, and feelings. [Participant 38] 
Patients will always want the human connection and if not from psychiatrists than 
shamans, natural healers, or other alternative practitioners. [Participant 534] 
Taking an opposing view, a few psychiatrists suggested that future technology might improve on 
human interactions; for example: 
People interacting with machines is much easier than with fellow human beings. 
We are assessing this phenomenon today when children are having “best friends” 
who they have only met through Facebook. It is very comfortable to have an 
“avatar” as a friend. Because, we select when to cut them off. [Participant 413] 
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Would do a better job than our autism and ADHD service most staff [of] which 
are empathic as a robot anyway. [Participant 782] 
When I accept patients that have seen other providers in my town, I am ever 
amazed and disappointed in the report of the care they’ve received. Seems 
patients don’t seem to connect with doctors (or any provider for that matter) any 
more. So if there is no interpersonal connection/relationship, why not type into a 
computer?  [Participant 95] 
Telepsychiatry 
Only a few participants predicted an increase in the use of telepsychiatry including the use of 
“psychotherapy via Skype”. Notably, these comments tended to be neutral with respect to the 
potential benefits or harms of telepsychiatry on doctor-patient interactions; for example: 
Telepsychiatry will prevail. [Participant 458] 
Telemedicine – face-to-face contact no longer required. [Participant 602] 
Trust, privacy, and confidentiality 
Similarly, implications for the fiduciary doctor-patient relationship also received very limited 
attention. However, some comments suggested that patients would not find technology 
acceptable in their care leading to lower rates of satisfaction, resistance, or even refusal to be 
treated. For example: 
Potential harms include alienating or breeding distrust in patients. [Participant 
364] 
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I can see trust as an issue, in someone who knows they’re interacting with a 
computer which could then block or greatly limit potential benefits. [Participant 
771] 
The great disadvantage of impersonal treatment via an app will only convince a 
few patients. [Participant 149] 
I suspect that there may be feelings of antipathy towards AI/tech due to job 
displacement which would not make for very therapeutic interactions. [Participant 
364] 
For others, trustful interactions could be vulnerable to exploitation or manipulation from patients, 
including faking illnesses; for example: 
If a patient simulates a disease AI might not be able to determine it. [Participant 
124] 
Machines could be manipulated by sociopaths. [Participant 548] 
However, one psychiatrist took an opposing and more optimistic view, responding that patients 
may exhibit greater trust in technology than in clinicians: 
People will have the confidence in bold technology as they’ll feel more confident 
that they can be treated more safely. [Participant 779] 
The topic of data safety, misuse of data, and questions of privacy, received only a small number 
of truncated comments; for example: 
Can’t keep patients’ privacy – the data will be hacked. [Participant 758] 
My only worry would be data sharing arrangements. [Participant 62] 
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Only one participant suggested that mental health patients may be at greater risk of harm from 
loss of confidentiality with new technologies:  
Given how vulnerable mentally ill patients are, AI must be monitored carefully. 
Already senior citizens fall for financial scams and predators targeting them. It 
would be important to protect confidentiality. [Participant 79] 
 
Impact of Future Technology on the Quality of Patient Medical Care 
Implications of future technology for patient care received considerable attention, and a mixture 
of opinions were offered about potential benefits and harms.  
Medical error 
Many respondents suggested that technology would reduce errors or improve accuracy in clinical 
decisions – including in diagnostics and treatment decisions. For example: 
Eliminate the human error. [Participant 50] 
Will speed up diagnosis and assess patient’s condition more accurately. 
[Participant 583] 
The benefits would be greater reliability in diagnosis and prognosis, being able to 
choose specific customized treatment plans after analysis. [Participant 562] 
A few comments suggested that technology could improve care by identifying drug-drug 
interactions or potential contraindications to treatment; for example: 
I think it can help identify safer prescribing/dangerous combinations, (…) data 
analysis of risk factors to recommend treatment setting. [Participant 359] 
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Watching drug interactions and appropriate options of meds. [Participant 63] 
More broadly, a minority of comments were very enthusiastic about the role of 
technology in patient care; for example: 
Only benefits: improvement in the care of the patient. I don’t see any harm. 
[Participant 155] 
Only improvements! [Participant 233] 
Clearer approach, no possible damage. [Participant 539] 
In contrast to these optimistic responses, however, a considerable number of comments 
suggested that future technology would lead to an increase in medical error. Many of these 
comments specifically referred to an increased risk of diagnostic error; for example: 
Damage: the wrong diagnoses, false positives, false negatives. [Participant 129] 
Automated assessments with limited and strict protocols may limit flexibility of 
treatment and diagnosis for complex cases. [Participant 65] 
This will lead to many misdiagnoses and inappropriate medications. [Participant 
419] 
Going further, some respondents were adamant about the lack of potential benefits of 
technology; for example: 
I don’t foresee any benefits at all. [Participant 713] 
Give a computer an ego and it will kill us all. [Participant 491] 
I cannot think of any possible benefits. [Participant 589] 
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Finally, opposing these polarized perspectives, some psychiatrists admitted that they were 
unfamiliar with the topic of artificial intelligence, and refrained from taking a position; for 
example: 
I am curious about the role of artificial intelligence. [Participant 573] 
I would like to know more about this topic. [Participant 186]. 
I don’t know and I wouldn’t know what to say about it… I have to get more 
familiar with the subject.  [Participant 629] 
Avoiding bias in clinical judgments 
Many participants anticipated that artificial intelligence would be “more objective”, “fairer”, or 
“unbiased” compared to human psychiatrists; for example: 
Less bias due to race or gender. [Participant 64] 
Computers can be objective and are not subject to recent recall of humans. 
[Participant 400] 
The advantage of AI is that a situation can be assessed/weighted without any 
personal bias. [Participant 710] 
Reduction in number of errors caused by emotional factors. [Participant 212] 
Improved detection and monitoring of mental health 
A number of respondents commented on the possibility for improved preventive mental health 
including earlier diagnosis and increased screening 
Early diagnosis advantage and therefore reduced the current slow diagnosis of 
certain diseases, improvement in prognosis – real prevention. [Participant 732] 
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Possibility of monitoring over a prolonged period, especially with repeated 
acute episodes that may be out of the practitioner’s field. [Participant 776] 
We will also have the ability to utilize AI or machine learning in assessing 
individual patient profiles in whatever capacity that is attainable at that time to 
supplement or replace universal screenings. [Participant 65] 
Artificial intelligence will help us to calculate odds, to evaluate the risk of 
suicide and to detect when a patient has a high risk of decompensation. 
[Participant 552] 
Other respondents felt technology might facilitate the monitoring of treatment regimens; for 
example: 
On the other hand, some comments were more doubtful that technology might aid preventive 
services; for example: 
Lack of identification of at risk situations. [Participant 188] 
Suicidal tendency will be difficult to detect. [Participant 123] 
Inefficiencies in determining risk factors. [Participant 693] 
 
Impact of Future Technology on the Profession 
Participants expressed a broad range of opinions about the impact of future technology on the 
profession: from outright replacement of psychiatrists to displacement of key functions of 
practice, and from skepticism about any change to uncertainty about the future. Responses also 
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indicated a wide array of attitudes about the potential to influence of the field, from very 
negative to very positive with many psychiatrists displaying neutral perspectives.  
The status of the profession 
A common perspective was that specific aspects of the job would gradually be replaced by 
artificial intelligence with some psychiatrists predicting that this would lead to outright 
elimination; for example:  
Jobs will reduce as AI will replace humans. [Participant 15] 
I believe psychiatrists (and physicians in general) will continue to be more and 
more marginalized by AI, and that more treatment decision making will be guided 
by AI in the future. [Participant 528] 
Some participants viewed change as a threat to the profession; for example: 
More interference with the process of doctoring. See no good coming from it.  
[Participant 27] 
The end of the psychiatrist profession. [Participant 144] 
However, a few disagreed; for example: 
Looking forward to artificial intelligence applications as quickly as possible. 
[Participant 586]. 
Facilitation of work activity  
Multiple comments predicted that future technology could facilitate the work of psychiatrists. 
Although most responses were rather short – for example, “facilitation”, or “it will make the job 
easy”; lengthier responses included:  
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This help could enable the psychiatrist to carry on with his work and to be more 
effective. [Participant 239] 
It will help to relieve the burden on psychiatrists. [Participant 268] 
A considerable number of comments indicated psychiatrists will need to control and verify the 
technology-based results since machine recommendations would likely be error-prone; for 
example:  
The problem is with being diagnosed by the machine. I think that the psychiatrist 
needs to verify the machine anyway. The machine cannot replace the human. 
[Participant 267] 
One potential harm is over reliance and not enough critical thinking about 
results, particularly results that support one's viewpoint. [Participant 381] 
Furthermore, multiple comments suggested that psychiatrists and future technology might have a 
“job sharing” arrangement with machines and humans complementing and enriching each other; 
for example:  
Assistance and simplification of our work will be possible and will be welcome, 
freeing us from mechanical and boring jobs and preserving human knowledge in 
order to used it in an optimal way at crucial times. [Participant 199] 
Many comments specified how future technology could facilitate the work activity of 
psychiatrists. Different aspects of the profession were discussed, and a major theme was the role 
of technology in improving administrative tasks, especially documentation: some respondents 
couched this as the only benefit to be accrued to psychiatric practice; for example: 
Only benefit would be with some documentation or ordering. [Participant 744] 
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The main benefit would be reducing paperwork to psychiatrists. [Participant 624] 
They would facilitate the bureaucratic work. [Participant 29] 
Not having to hunch over keyboards would be lovely. [Participant 91] 
However, not all participants agreed: a few believed that technology would lead to “more 
bureaucracy” and “an increase in “administrative work”; for example: 
AI represents bureaucracy and administrators, and we all hate them. [Participant 
47] 
Work intensification through an increased workload. [Participant 210] 
A few psychiatrists anticipated that future technology might play an important role in data-
gathering, however comments were typically truncated; for example:  
Few benefits except for data collection. [Participant 126] 
Data collection task is easier = benefit. [Participant 284] 
Better information, data-collection. [Participant 92] 
Some commented on perceived improvements with patient history-taking and the establishment 
of standardized tests and questionnaires; for example: 
Artificial intelligence could initially help to know the history, the anamnesis, and 
potentially the psychiatric symptoms. [Participant 239] 
There will probably be avatars capable of doing our work for us, in terms of 
performing clinical interviews. [Participant 647] 
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A related commonly perceived benefit was the provision of greater “consistency” or 
“standardization” in the application of evidence-based medicine and in clinical decision-making; 
for example: 
 AI may help psychiatrists to follow standardized protocols better, or to deviate 
from these protocols with better reasoning. [Participant 710] 
Benefits will be to standardize and minimize inter-psychiatrist variability across 
diagnoses. [Participant 577] 
Many comments indicated a role for “big data”, “algorithms”, and “data analysis” in 
augmenting clinical judgments but responses were limited and typically fell short of explanatory 
detail; for example: 
Data mining and deep learning. [Participant 387] 
Diagnosing and treatment recommendations will become more algorithm based. 
[Participant 396] 
Thorough data analysis (pattern matching, data mining). [Participant 381] 
Tools based on memory and finding correlation in data as well as having similar 
cases, and making comparisons, and making a suggestion based on predictive 
statistics. [Participant 670] 
With regard to decisions about treatment course, many respondents stressed that future 
technology will influence various areas, such as the formulation of the treatment plan, and 
medication decisions; for example:  
AI will strongly influence the technique of taking medical histories and be helpful 
in the selection of the best treatments. [Participant 291] 
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AI's ability to provide more complete information regarding patients' history and 
mental status will facilitate better management in terms of pharmacotherapy. 
[Participant 68] 
In contrast, only a minority of physicians suggested that future technology will assist in 
determining the “effectiveness of therapy” [Participant 113]. Similarly, the use of brain imaging, 
genetic testing, and use of AI in monitoring symptoms received only a small number of 
comments.  
Limited or negative impact on work activity  
Many responses strongly suggested a risk of “dependence” on artificial intelligence in clinical 
decisions that would be inherently problematic; for example: 
Risks include (…) overdependence of technology leading to complacency in the field or 
missing important information. [Participant 3] 
I feel a possible drawback would be in becoming too reliant on these advantages and 
becoming lost if there is a system failure [Participant 544] 
Dependence on technology = disadvantage. [Participant 547] 
A minority of comments also suggested that future technology might result in a reduction of 
psychiatric skills and that psychiatrists may lose their “critical thinking”; for example:  
May lead to less skilled mental health staff. [Participant 511] 
Decision-making process will be based on low-quality statistical data, and this is 
not in patient's interests. [Participant 238] 
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Going further, numerous comments were associated with considerable skepticism that future 
technology might ever replace the “art of medicine” and that technology would “oversimplify” 
decisions; for example:  
Psychiatry is an art. Not a science that you plug in symptoms into an algorithm 
and pop out a diagnosis and treatment plan and prognosis. [Participant 581] 
Medicine is not black-and-white, but it is unlikely that an artificial intelligence 
will be able to detect that and make appropriate medical decisions on a regular 
basis without human intervention. [Participant 44] 
More strongly, some psychiatrists surveyed stated that they do not expect future technology to 
impact the general professional status; for example:  
Inapplicable to psychiatry. [Participant 214] 
Will never work for psychiatry. Maybe benefits to other medical specialties. 
[Participant 744] 
It’s not really a concern. [Participant 676]. 
Hardly anything will change, because many evaluations based on experience 
depend particularly on the intuition of the physician. [Participant 123] 
I do not see psychiatry as changing much, it is one of the few fields that bases 
diagnoses on face to face interviews, non-verbal language etc. [Participant 154] 
Finally, multiple comments expressed uncertainties about the impact of technology on the status 
of the profession, with many psychiatrists admitting they were “unsure” or “don’t know”.  
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Consequences of Future Technology at a Systems Level  
Comments encompassed a number of themes related to the impact of future technology on 
psychiatry at a systems level. The majority of these responses tended to be optimistic, with 
comments focusing on greater access to psychiatric care; lower costs; and improved efficiencies.  
Access to care 
Many participants described the many ways that technology could increase access to care 
particularly in remote or underserviced settings; for example: 
It will be of great benefit in area where there is shortage of psychiatrists. 
[Participant 104] 
There is an already severe deficit for access to care to psychiatrist and this may 
bridge the gap. [Participant 374] 
It could improve the access to care and continuity of the same. [Participant 714] 
Benefits would be that patients can be seen in a timely fashion, as there is a 
shortage of psychiatrists and treatment facilities. [Participant 786] 
Costs 
Some psychiatrists speculated that technology could impact the cost of care. Many of these 
comments mentioned the potential benefit to health care organizations and insurance companies; 
for example: 
It will be possible to access treatments at lower cost. [Participant 685] 
The benefits are likely purely financial and in favor of large managed care orgs. 
[Participant 10] 
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The benefits exist in regards to cost savings to insurers and health care 
organizations. [Participant 528] 
Increased efficiencies 
Multiple participants commented on the potential for more efficient provision of care; for 
example:  
Efficiency, equity, and universality and sustainability. [Participant 185] 
Better organization of services and use of resources. [Participant 699] 
It will improve the relationship with the patient by delegating time dedicated to 
keeping records to computers. [Participant 708] 
I feel the potential benefit is to save time in analyzing certain data for trends and 
quicker analysis of complex histories and faster retrieval of vital information. 
[Participant 544] 
Scientific Innovation and Knowledge Translation 
Only a few comments highlighted the potential for technology to stimulate scientific 
advancement, such as the facilitation of knowledge translation, increased knowledge exchange, 
or more specifically the identification of new biological markers or neuroimaging techniques:  
Potential benefits: support in the exploratory, diagnostic and treatment process 
by considering all clinical variables and having scientific information always up 
to date. [Participant 649] 
Being able to obtain the right information on all accumulated advances and 
experience in psychiatric treatment. (…) Exchange with colleagues about the 
development in neuro-imaging techniques and description of these by experts at a 
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distance, making these increasingly affordable and easy to do, as well as at a 
lower cost. [Participant 743] 
As data points increase, with the addition of microbiomes, it will be necessary to 
have AI there to crunch the data into meaningful and interpretable factors 
guiding approaches toward wellness. [Participant 523] 
 
Discussion 
Principal Findings 
This extensive qualitative study provides cross-cultural insight into the views of practicing 
psychiatrists about the potential influence of future technology on psychiatric care (see Box 1). A 
dominant perspective was that machines would never be able to replace relational aspects of 
psychiatric care, including empathy and from developing a therapeutic alliance with patients. For 
the majority of psychiatrists these facets of care were viewed as essentially human capacities.  
Psychiatrists’ expressed divergent views about influence of future technology on the status of the 
profession and the quality of medical care. At one extreme, some psychiatrists considered 
outright replacement of the profession by AI was likely; yet others believed technology would 
incur no changes to psychiatric services. Many speculated that AI would fully undertake 
administrative tasks such as documentation, the vast majority of participants predicted that ‘man 
and machine’ would collaborate to undertake key aspects of psychiatric care such as diagnostics 
and treatment decisions. Participants were split over whether AI would might ultimately reduce 
medical error, or improve diagnostic and treatment decisions. Although many believed that AI 
could augment doctors’ roles, they were skeptical that technology would ever be able to fully 
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undertake medical decisions without human input. For many participants diagnostics and other 
clinical decisions were quintessentially human skills. Relatedly, risk of overdependence on 
technology in driving medical error was a common concern.  
More positively, many respondents felt technology would be fairer and less biased than humans 
in reaching clinical decisions. Similarly, participants expressed optimism that technology would 
play a key role in undertaking administrative duties, such as documentation. Other expected 
benefits from future technology included improved access to psychiatric care, reduced costs, and 
increased efficiencies in healthcare systems. 
Technology and Human Interactions 
Although psychiatrists, like informaticians, were optimistic that technology would increase 
access to psychiatric care, particularly among underserved populations,[] they were cynical that 
technological advancements could fully replace the provision of human-mediated empathy and 
relational aspects of care. These views are also shared by many AI experts who also argue that 
by outsourcing some aspects of medical care to machine learning, physicians will be freed up to 
invest more time on humanistic elements of medicine, including the provision of longer, face-to-
face doctor-patient interactions.[] Nonetheless, drawing on findings in the nascent field of 
affective computing, it is worth noting that some informaticians speculate that in the long-term, 
computers may play a critical role in augmenting or replacing human-mediated empathy; for 
example, emerging studies suggest that under certain conditions, computers can surpass humans 
when it comes to accurate detection of facial expressions, and personality profiling.[]  
Interestingly, very few psychiatrists discussed telepsychiatry despite its potential to increase 
patient access and adherence to care, however this may have been due to the emphasis on 
machine learning and artificial intelligence. Technical quality and issues of privacy and 
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confidentiality remain key drawbacks with this medium (see: Regulation of mHealth and Ethical 
Issues, below) but patients report high levels of satisfaction, convenience, and comfort with this 
approach, and evidence indicates that telepsychiatry provides comparable reliability and clinical 
outcomes as face-to-face consultations.[] Similarly, despite a growing body of research to 
support digital cognitive behavioral therapy,[] there was limited discussion among psychiatrists 
about the role of future technology encroaching on psychological treatments.   
The Scope of AI in Psychiatry 
Responses revealed that psychiatrists have myriad, often disparate views about the value of 
artificial intelligence on the future of their profession. Notwithstanding the wide spectrum of 
opinion, similar to the views of many experts, a dominant, overarching theme was speculation 
about a hybrid collaboration between ‘man and machine’ in undertaking psychiatric care.[] Like 
informaticians, in particular, many participants highlighted the potential for AI in risk detection 
and preventative care.[] More generally, psychiatrists – like informaticians – were optimistic 
about the benefits of AI in augmenting patient care, ergonomic and human factors remain 
ongoing issues in the design of technology. Without due attention to “alert fatigue” and clinical 
workflow, it is unclear whether AI applications will reap their anticipated potential in improving 
clinical accuracy, and in strengthening healthcare efficiencies. and reducing costs.[]  
Although a considerable number of participants conceived of clinical decisions as essentially and 
ineffably, a human “art”, biomedical informaticians argue that the ability to mine large scale 
health data for patterns in diagnosis and behavior is where machine learning presents 
unprecedented potential to disrupt diagnostic, prognostic, and treatment precision, yielding 
insights about hitherto undetected subtypes of diseases.[] Against the promise of pattern 
detection mediated by machine learning, many informaticians acknowledge that current AI is far 
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from sufficient to fully undertake diagnostic decisions unaided, and significant breakthroughs 
will be necessary if machines are to avoid pitfalls in reasoning, and demonstrate causal and 
counterfactual reasoning capacities necessary to reach accurate medical decisions.[] Importantly, 
however, and in contrast to many of the physicians surveyed who considered clinical reasoning 
to be, in essence, a necessarily human capacity, leading AI experts assume that one cannot rule 
out, a priori, the possibility that technology may one day be fully capable of fulfilling these key 
medical tasks. 
Technology and Data-collection 
Disparities between psychiatrists and AI experts were apparent in respect of some key 
developments and debates about the use of technologies in mental health. For example, only a 
minority of psychiatrists discussed – whether positively or negatively – the role of smart phones 
in data gathering. So far, however, encouraging evidence demonstrates that utilizing customized 
smart phone apps with patient health questionnaires can help to capture patients’ symptoms in 
real-time, allowing more sensitive diagnostic monitoring.[]  
Aside from health information gathered via electronic health records and patient reports, an 
exponentially increasing volume of data accumulated via in situ personal digital devices, 
especially smartphones usage. Social media posts, apps, purchases, and personal internet history, 
are already being used to support predictions about patient health, behavior, and wellbeing;[] 
other passively accumulated data from GPS, accelerometer sensors, text and call logs, and screen 
on/off time can be used to infer mobility, sociability, and other behaviors of smartphone users. 
Collectively, so-called ‘digital phenotyping’ provides a novel, indirect, and nontraditional route 
to yield inferences about patients’ health status; it also presents a novel challenge to orthodox 
boundaries of traditional medical expertise.[] Scarce reflection on these issues among 
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respondents contrasts with the predictions of biomedical informaticians who argue that apps and 
mobile technologies will play an increasing role in accumulating salient personal health 
information. Wearable devices, it is argued, will help to facilitate real-time monitoring of signs 
and symptoms, improving accuracy and precision in information gathering, and helping to avoid 
barriers associated with routine check-ups, such as missed appointments, personnel shortages, 
and costs on mental health services.[]  
Patients’ Preferences and Mobile Health 
Some psychiatrists argued that interfacing with technology would not be acceptable to many 
patients who would prefer to receive care from doctors. Previous survey research in mobile 
health (mHealth) undermines the certitude of these claims; for example, a study by Boeldt and 
colleagues found that patients were more comfortable with the use of technology performing 
diagnostics than physicians.[] Studies also show that patients from diverse socioeconomic and 
geographical regions express willingness to use apps to support symptom tracking, and illness 
self-management.[] Evidence also suggests that some patients with schizophrenia already use 
technology to manage their symptoms, or for help-seeking.[] In one recent US survey of 457 
adults identifying with schizophrenia, and schizoaffective disorders, 42% “often” or “very often” 
reported listening to music or audio files to help block or manage voices; 38% used calendar 
functions to manage symptoms, or sent alarms or reminders; 25% used technology to develop 
relationships with other individuals who have a lived experience related to mental illness; and 
23% used technology to identify coping strategies.[]  
Indeed, previously it was assumed that severity of mental health symptoms would pose a barrier 
to interest in mHealth;[] however, studies show that patients with serious conditions, including 
psychosis, indicate high levels of interest in the use of mobile applications to manage and track 
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their symptoms and illness.[] As Torous et al argue, it may be that patients are more comfortable 
using mobile technology to report and monitor symptoms than earlier methods such as sending 
text messages to clinicians, and that such a medium reduces stigma.[] Relatedly, the co-
production of medical notes – for example, patients entering information via semi-structured 
online questions prior to medical appointments – may also play a role in reducing barriers to 
help-seeking.[] Although research is ongoing, initial disclosures of symptoms via online patient 
portals may mitigate stigmatization and feelings of embarrassment in initiating conversations 
about mental health issues with physicians. 
Despite patient interest and evidence of high adoption rates for health and wellness apps, there 
remain well documented problems with drop off rates, and how to design for continuance – 
issues that surveyed psychiatrists did not directly discuss.[]  
Regulation of mHealth 
Conspicuously, participants provided scarce commentary about the regulatory ramifications of 
artificial intelligence on patient care. An estimated excess of 10,000 apps related to mental health 
are now available for download; the vast majority of these apps have not been subject to 
randomized controlled trials (RCTs), and many may even provide harmful ‘guidance’ to users.[] 
While recent meta-analyses and systematic reviews indicate that a number of safe, evidence-
based apps exist for monitoring symptoms of depression, and schizophrenia, and for reducing 
symptoms of anxiety, patients and clinicians lack adequate guidelines to facilitate 
recommendations.[]  
On the other hand, many psychiatrists expressed enthusiasm about the potential of future 
technology to provide more objective, and less biased clinical judgments. This optimism 
appeared to overlook concerns associated with “algorithmic biases” – the risk of discrimination 
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against patients, associated with inferior design and implementation of machine learning 
algorithms.[] As AI experts and ethicists warn, bias can become baked into algorithms when 
demographic groups (for example, along the lines of ethnicity, gender, or age) are 
underrepresented in training phases of machine learning. Without adequate regulatory standards, 
in the design and ongoing evaluation of algorithms, medical decisions informed by machine 
learning may exacerbate rather than diminish discrimination arising in clinical contexts. 
The US Food and Drug Administration (FDA) has so far adopted a deliberately cautious 
approach to clarifying medical software regulations.[] Some tech companies have emerged as, 
“default arbiters and agents responsible for releasing (and on some occasions, withdrawing) 
applications”.[] As medical legal experts warn, allowing unregulated market forces to determine 
‘kitemarks’ of medical standards, is inadequate to protect patient health.[]  
Ethical Issues 
Related to regulatory issues, few comments – only nine in total – weighed in on ethical issues 
related to protections for sensitive personal data. Loss of patient data and privacy remain serious 
concerns for mobile applications and telepsychiatry. In 2018 the European Union (EU) enacted 
its ‘General Data Protection Regulation’ (GDPR) aimed at ensuring citizens have control of their 
data, and provide consent for the utilization of their sensitive personal information. The US has 
considerably weaker data privacy rules, and while similar legislation to the GDPR is mooted to 
come into effect in California in January 2020, no comparable laws have been enacted at a 
federal level in the USA nor is there legislative enthusiasm to do so. Notably, these issues have 
prompted much recent media coverage. Given the gravity of ethical issues surrounding adequate 
oversight for patient data gathering from apps and mobile technologies, including how they 
might impact doctor-patient relationships and adequate patient care, and the media coverage that 
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these issues have prompted, it was conspicuous that privacy and confidentiality considerations, 
received scarce commentary from surveyed psychiatrists.[] Similarly, while may psychiatrists 
believed future technology would be a boon to patient access, issues of justice related to the 
‘digital divide’ – between those who have ready access to the internet and mobile devices, and 
those who did not – received no attention. 
Strengths and Limitations 
To our knowledge this is the first survey to undertake qualitative research aimed at 
understanding psychiatrists’ views about how AI/ML will impact their profession. The themes 
support and expand on findings of an earlier quantitative survey by providing a more refined 
perspective of psychiatrists’ opinions about AI and the future of their profession. Utilizing the 
Sermo platform enabled us to gain rapid responses from verified and licensed physicians from 
across the world, and this survey benefits from a relatively large sample size of participants 
working in different countries across a broad spectrum of practice settings. The diversity of 
respondents combined with the unusually high response rate for questions requesting comments, 
are major strengths of the survey.  
The study has a number of limitations. Comments were often brief, and because of the 
restrictions of online surveys it was not possible to obtain a more nuanced understanding of 
participants’ views. Therefore, although a rich and diverse range of opinions was gathered, 
further qualitative work is warranted to obtain more fine-grained analysis of physicians’ opinions 
about the impact of AI/ML on the practice of psychiatry and on patient care. Furthermore, we did 
not gather information on physicians’ level of knowledge or exposure to the topic or AI/ML in 
medicine, limiting inferences about awareness, and the depth of participants’ reflections. 
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Notably, some participants explicitly expressed uncertainty about whether AI could benefit 
medical judgment with some admitting they had limited familiarity with the field. 
In-depth qualitative interviews, or focus groups would help to facilitate deeper analysis of 
psychiatrists’ perspectives and their understanding of these fields and their impact on psychiatry. 
We further recommend that follow-up qualitative work related to these themes should focus on 
the views of other mental health professionals, including mental health nurse practitioners, 
psychiatric nurses, clinical psychologists and psychotherapists, and other counselors. Finally, 
there can be no complete account of the anticipated benefits, harms, and hopes for AI in 
psychiatry without the ongoing input of mental health patients, and their caregivers. 
Conclusions 
This study provides a foundational exploration of psychiatrists’ views about the future of their 
profession. Perceived benefits and limitations of future technology in psychiatric practice, and 
the future status of the profession, have been elucidated. A variety of perspectives were 
expressed reflecting a wide range of opinions. Overwhelmingly, participants were skeptical 
about the role of technology in providing empathetic care in patient interactions. Although some 
participants expressed anxiety about the future of their job, viewing technology as a threat to the 
status of their profession, the dominant perspective was a prediction that human medics and 
future technology would work together. However, participants were divided over whether this 
collaboration might ultimately improve or harm clinical decisions including diagnostics and 
treatment recommendations, and overreliance on machine learning was a recurrent theme. 
Similar to biomedical informaticians, participants were also hopeful that technology might 
improve care at a systems level, improving access, increasing efficiencies, and lowering 
healthcare costs.  
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While psychiatrists’ opinions often mirrored the predictions of AI experts, results also revealed 
worrying omissions in respondents’ comments. In light of high levels of patient interest in 
mental health apps, the effectiveness, reliability, and safety of machine learning technologies 
present serious ethical, legal, and regulatory considerations that require the sustained 
engagement of the psychiatric community.[] So far, the efficacy and safety of the overwhelming 
majority of downloadable mHealth apps have yet to be demonstrated.[] Moreover, in contrast to 
the views of many leading informaticians, psychiatrists were often enthusiastic that technology 
would reduce biases in decision-making; however, without further regulatory attention to 
standards of design within machine learning, it is unclear that algorithms will help to redress 
rather than deepen healthcare disparities. Against these considerations, steadfast leadership is 
required from the psychiatric community to help patients navigate mobile health apps, and to 
advocate for guidelines with respect to digital tool, to ensure current mHealth as well as 
emerging technologies, do not jeopardize standards of safety and trust in patient care.  
Finally, given the sheer breadth of opinion, and oversights,[] it is conceivable that many 
practitioners are disengaged from the literature on healthcare AI.[] Recent physician surveys 
suggest medical education on health technology “leaves much room for improvement”.[] For 
example, an extensive cross-sectional survey of EU medical schools found that fewer than a third 
(90/302, 30%) offered any kind of health information technology training as part of medical 
degree courses. Similarly, a recent survey of physicians in South Korea reported that only 6% 
(40/669) of those surveyed described “good familiarity with AI”.[] While gaps in knowledge are 
understandable given the volume of medical course curricula and the time pressures of clinical 
practice, we conclude that the medical community must do more to raise awareness of AI among 
current and future physicians. Lacking adequate education about machine learning technology 
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and its potential to impact the lives of patients, psychiatrists will be ill-equipped to steer mental 
health care in the right direction.  
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Table 1. Open Comment Questions embedded in Survey 
 
1. Please briefly describe the way(s) you believe artificial intelligence/machine learning will 
change psychiatrists’ jobs in the next 25 years.* 
2. Please provide any brief comments you may have about the potential benefits and/or potential 
harms of artificial intelligence/machine learning in psychiatry. 
3. We value your opinion. If you have any other comments about this survey topic or 
recommendations for other questions we should include, please add them below. 
 
* All participants were requested to respond to Questions 2 and 3. However, Question 1 was 
preceded by the following question: “In 25 years, of the following options, in your opinion what is the 
likely impact of artificial intelligence/machine learning on the work of psychiatrists”. Options included 
“No influence (jobs will remain unchanged)”, “Minimal influence (jobs will change slightly)”; “Moderate 
influence (jobs will change substantially)” or “Extreme influence (jobs will become obsolete)”. 
Participants who selected the first response [“No influence (jobs will remain unchanged)”] were not 
invited to respond to Question 1. 
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Table 2: Respondent Characteristics 
Characteristic Psychiatrists (n=791) 
Percentage  
Gender  
Male 69.5 
Female 29.2 
Other 0.1 
Prefer not to say 1.1 
  
Age  
25-34 9.7 
35-44 29.3 
45-54 26.7 
55-64 24.7 
65 and over 9.6 
  
Race/ethnicity  
Asian 17.6 
Black/African/Caribbean 2.0 
Mixed/Multiple ethnic groups 3.7 
White 64.3 
Other ethnic group not listed 3.2 
Prefer not to say  9.3 
  
Practice type  
Private practice 35.0 
Public clinic 52.0 
Academia 13.0 
  
Country where psychiatrist practices  
United States 34.9 
France 9.7 
Italy 9.4 
Germany 7.5 
Spain 7.2 
United Kingdom 6.3 
Russian Federation 3.8 
Australia 3.2 
Japan 2.8 
Mexico 2.5 
Canada 2.3 
Greece 1.9 
China 1.8 
Brazil 1.5 
Turkey 1.4 
Netherlands 1.0 
Belgium 0.5 
Switzerland 0.4 
Norway 0.3 
Portugal 0.3 
India 0.1 
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Box 1: Key questions and findings 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
What is already known about this topic? 
 Informaticians and experts in artificial intelligence (AI) argue that big data and machine learning (ML) 
have the potential to revolutionize how psychiatric care is delivered. 
 Recent survey evidence suggestions that psychiatric patients, including those suffering from severe 
mental illness express an interest in using mobile technologies to monitor and manage their condition(s). 
 To date, in excess of 10,000 apps related to mental health are available to download; the vast majority 
have not been subject to RCTs. 
 Indirectly, data accumulated from in situ personal digital devices can also be used to support predictions 
about patient health, behavior, and wellbeing – this is known as ‘digital phenotyping’. 
 
What are the new findings? 
 791 psychiatrists from 22 countries responded to an online survey via the physician social networking 
platform Sermo; 70% were male; 61% were aged 45 or older. 
 Overwhelmingly, psychiatrists were skeptical that machines could replace humans in the delivery of 
empathic care, and in forging therapeutic alliances with patients. 
 Many predicted that in the future ‘man and machine’ would increasingly collaborate on key aspects of 
psychiatric care, such as diagnostics and treatment decisions; psychiatrists were divided over whether 
technology would augment or diminish the quality of medical decisions and patient care. 
 In contrast to concerns of AI experts, psychiatrists provided limited or no reflection about issues relating 
to digital phenotyping, and regulatory and ethical considerations related to mobile health.  
